![Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study - The Lancet Microbe Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study - The Lancet Microbe](https://www.thelancet.com/cms/asset/0d430051-a050-46b2-8635-9e36f04f80c9/gr1.jpg)
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study - The Lancet Microbe
![Study suggests new coronavirus may remain on surfaces for days | National Institutes of Health (NIH) Study suggests new coronavirus may remain on surfaces for days | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/styles/floated_media_breakpoint-medium/public/news-events/research-matters/2020/20200324-covit-19.jpg?itok=2nxv6QTY×tamp=1584981675)
Study suggests new coronavirus may remain on surfaces for days | National Institutes of Health (NIH)
![SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - ScienceDirect SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867420302294-fx1.jpg)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - ScienceDirect
![Frontiers | Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments Frontiers | Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments](https://www.frontiersin.org/files/MyHome%20Article%20Library/572329/572329_Thumb_400.jpg)
Frontiers | Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments
![Ricerca: vaccinazione e guarigione producono anticorpi che proteggono da molte varianti utili per nuovi vaccini - Virologia Today Ricerca: vaccinazione e guarigione producono anticorpi che proteggono da molte varianti utili per nuovi vaccini - Virologia Today](https://www.virologia.today/wp-content/uploads/2022/09/covid_2008733912.jpg)
Ricerca: vaccinazione e guarigione producono anticorpi che proteggono da molte varianti utili per nuovi vaccini - Virologia Today
![Peptidi antimicrobici da pelle di anfibio: potenziali nuovi agenti antivirali contro la pandemia di SARS-COV-2 | Facoltà di Farmacia e Medicina Peptidi antimicrobici da pelle di anfibio: potenziali nuovi agenti antivirali contro la pandemia di SARS-COV-2 | Facoltà di Farmacia e Medicina](https://web.uniroma1.it/farmaciamedicina/sites/default/files/Mangoni_ML_et%20al_FM%20-%20Marialuisa%20Mangoni.jpg)
Peptidi antimicrobici da pelle di anfibio: potenziali nuovi agenti antivirali contro la pandemia di SARS-COV-2 | Facoltà di Farmacia e Medicina
![Global Study Identifies Common Vulnerabilities Across SARS-CoV-2, SARS-CoV-1 and MERS Coronaviruses - Georgia State University News - Coronavirus Research, Faculty, Institute for Biomedical Sciences, Press Releases, Research, University Research - Health & Global Study Identifies Common Vulnerabilities Across SARS-CoV-2, SARS-CoV-1 and MERS Coronaviruses - Georgia State University News - Coronavirus Research, Faculty, Institute for Biomedical Sciences, Press Releases, Research, University Research - Health &](https://news.gsu.edu/files/2020/03/coronavirus1.jpg)